Trial Profile
PD-L1 and PD-L2 Peptide Vaccination as Consolidation for Relapsed Follicular Lymphoma
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs IO-103 (Primary)
- Indications Follicular lymphoma
- Focus Adverse reactions; First in man
- 11 Aug 2020 Status changed from active, no longer recruiting to completed.
- 21 Feb 2019 Status changed from recruiting to active, no longer recruiting.
- 13 Apr 2018 New trial record